Multimodality Management of Head and Neck Cancer: A Phase II Trial of Induction Chemotherapy, Organ Preservation Surgery, and Concurrent Chemoradiotherapy.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Cisplatin; Docetaxel; Fluorouracil; Folinic acid; Gemcitabine
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Jan 2021 Biomarkers information updated
- 17 Dec 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 26 Nov 2012 Planned End Date changed from 1 Oct 2012 to 1 Dec 2013 as reportyed by ClinicalTrials.gov.